Lubrizol LifeSciences to Showcase Expanded Solutions at Medtec EU 2017
(Thomson Reuters ONE) -
News Release
Lubrizol LifeSciences to Showcase Expanded
Medical Device Solutions at Medtec EU 2017
CLEVELAND, April 4, 2017 -The Lubrizol Corporation's LifeSciences business will
showcase its total solutions capabilities at Medtec Europe 2017 (Booth #1N25),
April 4-6 at Messe Stuttgart in Stuttgart, Germany. Lubrizol LifeSciences is
uniquely positioned as the only medical solutions partner offering polymer
customization, development services for drug eluting devices and contract
manufacturing services.
This year at Medtec Europe, Lubrizol LifeSciences will highlight new compounding
capabilities for Pellethane(®) TPU and Isoplast(®) ETPU products. Lubrizol's new
compounding offering includes color matching and custom colors for brand
recognition, safe identification, and aesthetics in medical device applications,
as well as compounding of radiopacifiers such as barium and tungsten for X-ray
identification and proper device positioning. This new offering complements
Lubrizol LifeSciences' portfolio of full service capabilities enabling the
simplification of customer's supply chain and ensuring success in the medical
device industry.
"When customers partner with Lubrizol LifeSciences, they benefit from working
with us at every stage in their development process," states Robert Miller,
general manager, Lubrizol LifeSciences. "With a long history of polymer
expertise and recent investments, Lubrizol LifeSciences is positioned to offer
full-service development for next generation medical and drug-eluting device
innovations."
To show further commitment to the medical and drug-eluting device markets,
Lubrizol LifeSciences has invested significantly to expand its global
development and manufacturing facilities, positioning Lubrizol to better serve
the growing market for medical device development and contract manufacturing.
This capital investment will expand multiple facilities and increase Lubrizol
LifeSciences' in-house engineering capacity for both silicone and thermoplastic
products. Part of this investment expands Vesta's thermoplastic capabilities to
include tip forming, tube flaring, pad printing, hole punching/drilling,
precision cutting, reflow, braided tubing lamination and more.
Vesta offers custom contract manufacturing services, including precision
silicone and thermoplastic extrusion as well as comprehensive silicone
fabrication. With decades of experience, the company's service, engineering
expertise and commitment to quality are sought by customers worldwide.
- more -
About Lubrizol LifeSciences
Lubrizol LifeSciences is a healthcare solution partner that provides customer
support from idea to execution by supplying customizable polymers and
excipients, complex drug formulation development and best-in-class contract
manufacturing services for medical device and pharmaceutical manufacturers. The
combination of our polymer expertise, drug formulation development and quality
contract manufacturing allows Lubrizol LifeSciences to offer our customers end-
to-end solutions for success in the medical device and drug delivery market.
About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven
global company that combines complex, specialty chemicals to optimize the
quality, performance and value of customers' products while reducing their
environmental impact. It is a leader at combining market insights with chemistry
and application capabilities to deliver valuable solutions to customers in the
global transportation, industrial and consumer markets. Lubrizol improves lives
by acting as an essential partner in our customers' success, delivering
efficiency, reliability or wellness to their end users. Technologies include
lubricant additives for engine oils, driveline and other transportation-related
fluids, industrial lubricants, as well as additives for gasoline and diesel
fuel. In addition, Lubrizol makes ingredients and additives for home care,
personal care and skin care products and specialty materials encompassing
polymer and coatings technologies, along with polymer-based pharmaceutical and
medical device solutions.
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing
facilities in 17 countries, as well as sales and technical offices around the
world. Founded in 1928, Lubrizol has approximately 8,300 employees worldwide.
Revenues for 2016 were $6.5 billion. For more information, visit Lubrizol.com..
Vesta Inc. is part of Lubrizol Advanced Materials, Inc.
Pellethane(®) and Isoplast(®) are registered trademarks of The Lubrizol
Corporation.
Media Contact
Ben Patti
(216) 447-5827
www.lubrizol.com/LifeSciences
www.vestainc.com
###
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 04.04.2017 - 08:30 Uhr
Sprache: Deutsch
News-ID 534205
Anzahl Zeichen: 5801
contact information:
Town:
Wickliffe, Ohio
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 145 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Lubrizol LifeSciences to Showcase Expanded Solutions at Medtec EU 2017"
steht unter der journalistisch-redaktionellen Verantwortung von
Lubrizol (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
